Korea Investment Corp Seagen Inc. Transaction History

Korea Investment Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$191.51 - $216.16 $7.42 Million - $8.38 Million	38,751 Added 35.3%	148,521 $31.5 Million
Q2 2023 Aug 11, 2023	SELL	$187.64 - $206.25 $1.32 Million - $1.45 Million	-7,016 Reduced 6.01%	109,770 $21.1 Million
Q1 2023 May 12, 2023	SELL	$127.59 - $203.08 $506,404 - $806,024	-3,969 Reduced 3.29%	116,786 $23.6 Million
Q4 2022 Feb 13, 2023	SELL	$117.37 - $139.17 $4.61 Million - $5.47 Million	-39,319 Reduced 24.56%	120,755 $15.5 Million
Q3 2022 Nov 10, 2022	BUY	$135.27 - $180.11 $6.75 Million - $8.98 Million	49,870 Added 45.25%	160,074 $21.9 Million

Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $7.81 Million - $12.9 Million	71,804 Added 186.99%	110,204 $19.5 Million
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $1.54 Million - $2.04 Million	12,900 Added 50.59%	38,400 $5.53 Million
Q4 2021 Feb 09, 2022	BUY	$142.57 - $190.86 $327,911 - $438,978	2,300 Added 9.91%	25,500 $3.94 Million
Q3 2021 Nov 12, 2021	SELL	$142.45 - $169.82 $911,679 - $1.09 Million	-6,400 Reduced 21.62%	23,200 $3.94 Million
Q2 2021 Aug 12, 2021	BUY	$135.08 - $161.1 $189,112 - $225,540	1,400 Added 4.96%	29,600 $4.67 Million
Q1 2021 May 13, 2021	SELL	$137.51 - $190.8 $880,064 - $1.22 Million	-6,400 Reduced 18.5%	28,200 $3.92 Million
Q4 2020 Feb 10, 2021	BUY	$164.63 - $211.93 $5.7 Million - $7.33 Million	34,600 New	34,600 $6.06 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Korea Investment Corp with notifications on news.